Abstract: At present, transurethral resection of the prostate, as the internationally recognized "gold standard" for minimally invasive treatment of the prostate, has been selected by the vast majority of hospitals due to its advantages of no surgery, less bleeding, low surgical risk and rapid postoperative recovery